Colchicine 0.5 MG Oral Tablet clinical trials

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

This study, called LEADER-PAD, is looking into whether a low dose of colchicine, a common anti-inflammatory medicine, can help people with a condition called Peripheral Artery Disease (PAD) reduce their risk of serious heart and circulation problems.